These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 22284901)

  • 21. Comparison of rheumatoid arthritis care costs in patients starting therapy with leflunomide versus etanercept.
    Yazdani C; McLaughlin T; Cummins G; Doyle J
    Am J Manag Care; 2001 Sep; 7(13 Suppl):S419-26. PubMed ID: 11594238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initial disease modifying antirheumatic drugs and prednisolone prescriptions for patients with rheumatoid arthritis: a 15-year study.
    Osiri M; Akkasilpa S; Deesomchok U
    J Med Assoc Thai; 2000 Mar; 83(3):217-24. PubMed ID: 10808674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time to consultation and disease-modifying antirheumatic drug treatment of patients with rheumatoid arthritis--northern Alberta perspective.
    Nanji JA; Choi M; Ferrari R; Lyddell C; Russell AS
    J Rheumatol; 2012 Apr; 39(4):707-11. PubMed ID: 22337235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time to treatment for new patients with rheumatoid arthritis in a major metropolitan city.
    Jamal S; Alibhai SM; Badley EM; Bombardier C
    J Rheumatol; 2011 Jul; 38(7):1282-8. PubMed ID: 21572157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disease-modifying anti-rheumatic drug usage, prescribing patterns and disease activity in rheumatoid arthritis patients in community-based practice.
    Montag K; Gingold M; Boers A; Littlejohn G
    Intern Med J; 2011 Jun; 41(6):450-5. PubMed ID: 20403067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of venous thromboembolism in patients with rheumatoid arthritis: initiating disease-modifying antirheumatic drugs.
    Kim SC; Solomon DH; Liu J; Franklin JM; Glynn RJ; Schneeweiss S
    Am J Med; 2015 May; 128(5):539.e7-17. PubMed ID: 25534420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Initiation of disease-modifying antirheumatic drug therapy in minority and disadvantaged patients with rheumatoid arthritis.
    Suarez-Almazor ME; Berrios-Rivera JP; Cox V; Janssen NM; Marcus DM; Sessoms S
    J Rheumatol; 2007 Dec; 34(12):2400-7. PubMed ID: 17985405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality care in seniors with new-onset rheumatoid arthritis: a Canadian perspective.
    Widdifield J; Bernatsky S; Paterson JM; Thorne JC; Cividino A; Pope J; Gunraj N; Bombardier C
    Arthritis Care Res (Hoboken); 2011 Jan; 63(1):53-7. PubMed ID: 20806274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts.
    van der Woude D; Young A; Jayakumar K; Mertens BJ; Toes RE; van der Heijde D; Huizinga TW; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2262-71. PubMed ID: 19644846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment Patterns with Disease-Modifying Antirheumatic Drugs in U.S. Veterans with Newly Diagnosed Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis.
    Walsh JA; Pei S; Penmetsa GK; Sauer BC; Patil V; Walker JH; Clewell J; Douglas KM; Clegg DO; Cannon GW; Halwani A
    J Manag Care Spec Pharm; 2019 Nov; 25(11):1218-1228. PubMed ID: 31663467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of medication use during pregnancy in rheumatoid arthritis.
    Kuriya B; Hernández-Díaz S; Liu J; Bermas BL; Daniel G; Solomon DH
    Arthritis Care Res (Hoboken); 2011 May; 63(5):721-8. PubMed ID: 21557526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns of disease modifying antirheumatic drug use in a Spanish cohort of patients with rheumatoid arthritis.
    Gonzalez-Alvaro I; Carmona L; Balsa A; Sanmarti R; Belmonte MA; Tena X;
    J Rheumatol; 2003 Apr; 30(4):697-704. PubMed ID: 12672186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delay in initiation of DMARD or anti-inflammatory therapy in patients newly diagnosed with rheumatoid arthritis: An analysis of United States Military Health System TRICARE beneficiaries.
    Kimsey L; Weissman JS; Patel A; Drew A; Koehlmoos T; Sparks JA
    Semin Arthritis Rheum; 2019 Apr; 48(5):821-827. PubMed ID: 30190154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of anti-TNF treatment initiation in rheumatoid arthritis databases demonstrates wide country variability in patient parameters at initiation of anti-TNF therapy.
    Pease C; Pope JE; Truong D; Bombardier C; Widdifield J; Thorne JC; Paul Haraoui B; Psaradellis E; Sampalis J; Bonner A
    Semin Arthritis Rheum; 2011 Aug; 41(1):81-9. PubMed ID: 21168187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-dose prednisolone in rheumatoid arthritis: adverse effects of various disease modifying antirheumatic drugs.
    Malysheva OA; Wahle M; Wagner U; Pierer M; Arnold S; Häntzschel H; Baerwald CG
    J Rheumatol; 2008 Jun; 35(6):979-85. PubMed ID: 18412314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of leflunomide versus biologic agents on the costs of care for rheumatoid arthritis in a managed care population.
    Ollendorf DA; Peterson AN; Doyle J; Huse DM
    Am J Manag Care; 2002 May; 8(7 Suppl):S203-13. PubMed ID: 12022236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Second-line therapy with biological drugs in rheumatoid arthritis patients in German rheumatologist practices: a retrospective database analysis.
    Gossen N; Jacob L; Kostev K
    Rheumatol Int; 2016 Aug; 36(8):1113-8. PubMed ID: 26936261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends in antirheumatic medication use among patients with rheumatoid arthritis, 1981-1996.
    Ward MM; Fries JF
    J Rheumatol; 1998 Mar; 25(3):408-16. PubMed ID: 9517756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disappointing longterm results with disease modifying antirheumatic drugs. A practice based study.
    Galindo-Rodriguez G; Aviña-Zubieta JA; Russell AS; Suarez-Almazor ME
    J Rheumatol; 1999 Nov; 26(11):2337-43. PubMed ID: 10555887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "5D" Outcome in 52 patients with rheumatoid arthritis surviving 20 years after initial disease modifying antirheumatic drug therapy.
    Capell H; McCarey D; Madhok R; Hampson R
    J Rheumatol; 2002 Oct; 29(10):2099-105. PubMed ID: 12375318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.